Abstract

Human cationic and anionic trypsins are sulfated on Tyr154, a residue which helps to shape the prime side substrate-binding subsites. Here, we used phage display technology to assess the significance of tyrosine sulfation for the specificity of human trypsins. The prime side residues P1′–P4′ in the binding loop of bovine pancreatic trypsin inhibitor (BPTI) were fully randomized and tight binding inhibitor phages were selected against non-sulfated and sulfated human cationic trypsin. The selection pattern for the two targets differed mostly at the P2′ position, where variants selected against non-sulfated trypsin contained primarily aliphatic residues (Leu, Ile, Met), while variants selected against sulfated trypsin were enriched also for Arg. BPTI variants carrying Arg, Lys, Ile, Leu or Ala at the P2′ position of the binding loop were purified and equilibrium dissociation constants were determined against non-sulfated and sulfated cationic and anionic human trypsins. BPTI variants harboring apolar residues at P2′ exhibited 3–12-fold lower affinity to sulfated trypsin relative to the non-sulfated enzyme, whereas BPTI variants containing basic residues at P2′ had comparable affinity to both trypsin forms. Taken together, the observations demonstrate that the tyrosyl sulfate in human trypsins interacts with the P2′ position of the substrate-like inhibitor and this modification increases P2′ selectivity towards basic side chains.

Highlights

  • The human pancreas secretes two trypsinogen isoforms in large quantities, anionic and cationic trypsinogens, which account for more than 95% of total trypsinogen content in the pancreatic juice [1]

  • The P1 Lys residue was changed to Arg, and Val34 in the bovine pancreatic trypsin inhibitor (BPTI) scaffold (P199), which interacts with the P29 position, was randomized

  • In the present study we used phage display technology to investigate the significance of tyrosine sulfation in the substrate binding specificity of human cationic and anionic trypsins

Read more

Summary

Introduction

The human pancreas secretes two trypsinogen isoforms in large quantities, anionic and cationic trypsinogens, which account for more than 95% of total trypsinogen content in the pancreatic juice [1]. In our more recent studies, we isolated and identified the sulfated tyrosine amino acid from hydrolyzed pancreatic trypsinogens, and demonstrated that incorporation of radioactive sulfur was abolished by mutation of Tyr154 [6]. Autoactivation of human cationic trypsinogen was somewhat increased by sulfation but a similar effect was not observed with anionic trypsinogen [6,8]. We used phage display technology and inhibitor binding experiments to compare the prime side substrate specificity of non-sulfated and sulfated trypsins. These studies were motivated by the observation that Tyr154 is located on the prime. Side of the trypsin substrate binding cleft and appears to form part of the S29 subsite (Schechter and Berger nomenclature [14]), and sulfation may result in altered interactions between human trypsins and their inhibitors and substrates

Experimental Procedures
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call